Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envivo Bio’s CapScan® device enables non-invasive, multi-region sampling of the human gut under physiological conditions. Published studies in Nature and Nature Metabolism demonstrate its ability to profile the microbiome and metabolome with unprecedented spatial resolution, revealing new insights into diet-microbe-host interactions and differences between stool and intestinal samples.[1][4][5] The technology has been validated in landmark academic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envivo Bio.